AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 45,737 | -52,092 | -26,842 | -7,205 | 21,097 |
| Depreciation Amortization | 1,282 | 983 | 590 | 282 | 299 |
| Accounts payable and accrued liabilities | -1,857 | 883 | -2,900 | 2,632 | -147 |
| Other Working Capital | 5,687 | 1,853 | -2,022 | 3,349 | 25,587 |
| Other Operating Activity | 4,730 | 3,308 | 8,720 | -4,790 | -953 |
| Operating Cash Flow | $55,579 | $-45,065 | $-22,454 | $-5,732 | $45,883 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -65,423 | -30,672 | N/A | N/A | N/A |
| PPE Investments | -1,897 | -1,900 | -1,831 | -913 | -254 |
| Other Investing Activity | 0 | -182 | -41 | 0 | 0 |
| Investing Cash Flow | $-67,320 | $-32,754 | $-1,872 | $-913 | $-254 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 50,805 | 202 | 203 | N/A | N/A |
| Common Stock Issued | 69 | 114,032 | 72 | 70,755 | 91 |
| Other Financing Activity | -936 | -2,407 | 0 | 9,240 | 28,821 |
| Financing Cash Flow | $49,939 | $111,828 | $275 | $79,996 | $28,911 |
| Exchange Rate Effect | -831 | -1,205 | -4,236 | 3,496 | 1,663 |
| Beginning Cash Position | 157,479 | 127,163 | 154,691 | 77,693 | 3,441 |
| End Cash Position | 194,845 | 159,967 | 126,404 | 154,539 | 79,644 |
| Net Cash Flow | $37,366 | $32,804 | $-28,287 | $76,846 | $76,203 |
| Free Cash Flow | |||||
| Operating Cash Flow | 55,579 | -45,065 | -22,454 | -5,732 | 45,883 |
| Capital Expenditure | -1,897 | -1,900 | -1,831 | -913 | -254 |
| Free Cash Flow | 53,682 | -46,965 | -24,286 | -6,645 | 45,629 |